Table 1.
Treatment | Control | Overall | ||
---|---|---|---|---|
(N = 104) | (N = 96) | (N = 200) | P-value | |
Gender | 0.999 | |||
Female | 64 (61.5%) | 59 (61.5%) | 123 (61.5%) | |
Male | 40 (38.5%) | 37 (38.5%) | 77 (38.5%) | |
Cardiovascular disease | 0.999 | |||
No | 13 (12.5%) | 3 (3.1%) | 16 (8.0%) | |
Yes | 91 (87.5%) | 93 (96.9%) | 184 (92.0%) | |
Diabetes | 0.251 | |||
No | 66 (63.5%) | 53 (55.2%) | 119 (59.5%) | |
Yes | 38 (36.5%) | 43 (44.8%) | 81 (40.5%) | |
COPD | 0.033 | |||
No | 49 (47.1%) | 60 (62.5%) | 109 (54.5%) | |
Yes | 55 (52.9%) | 36 (37.5%) | 91 (45.5%) | |
Chronic renal failure | 0.069 | |||
No | 84 (80.8%) | 87 (90.6%) | 171 (85.5%) | |
Yes | 20 (19.2%) | 9 (9.4%) | 29 (14.5%) | |
Recent cancer | 0.825 | |||
No | 93 (89.4%) | 84 (87.5%) | 177 (88.5%) | |
Yes | 11 (10.6%) | 12 (12.5%) | 23 (11.5%) | |
Alcohol | 0.347 | |||
No | 78 (75.0%) | 66 (68.8%) | 144 (72.0%) | |
Yes | 26 (25.0%) | 30 (31.2%) | 56 (28.0%) | |
Coffee | 0.557 | |||
No | 14 (13.5%) | 16 (16.7%) | 30 (15.0%) | |
Yes | 90 (86.5%) | 80 (83.3%) | 170 (85.0%) | |
Tobacco | 0.448 | |||
No | 97 (93.3%) | 86 (89.6%) | 183 (91.5%) | |
Yes | 7 (6.7%) | 10 (10.4%) | 17 (8.5%) | |
Symptomatic Covid-19 | 0.015 | |||
No | 102 (98.1%) | 86 (89.6%) | 188 (94.0%) | |
Yes | 2 (1.9%) | 10 (10.4%) | 12 (6.0%) | |
Covid mortality | 0.480 | |||
No | 104 (100%) | 95 (99.0%) | 199 (99.5%) | |
Yes | 0 (0%) | 1 (1.0%) | 1 (0.5%) |